ReviewCureus2025
Prophylactic Laser and Cryotherapy in the Fellow Eye of Patients With Giant Retinal Tears: A Systematic Review and Meta-Analysis.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Giant retinal tears (GRTs) are associated with a substantial risk of rhegmatogenous retinal detachment (RD) in the fellow eye. Prophylactic retinal therapy, including laser photocoagulation and cryotherapy, is employed in particular individuals to reduce this risk; however, clinical consensus remains limited due to heterogeneous data. This systematic review and meta-analysis aimed to evaluate the effectiveness and safety of prophylactic treatment in preventing RD in the fellow eye of patients with unilateral GRT. A comprehensive literature search was performed via PubMed, ScienceDirect, the Cochrane Library, and ClinicalTrials.gov through July 2025. Patients with unilateral GRT who underwent either observation or prophylactic treatment in their fellow eyes were the subjects of eligible studies. Extracted data included associated risk factors, ocular and systemic comorbidities that might predispose to GRT formation, demographics, treatment modality, follow-up duration, and the incidence of RD or new GRT formation. Risk of bias was assessed using the Joanna Briggs Institute checklist. A random-effects meta-analysis was performed to calculate the pooled relative risk for RD in treated versus untreated fellow eyes, while heterogeneity was evaluated with the I² statistic and publication bias with funnel plots and Egger's test. A total of 803 fellow eyes were included across the eligible studies. Prophylactic treatment significantly reduced the risk of RD compared with observation (OR 0.14; 95% CI 0.07-0.28; p<0.001), with negligible heterogeneity (I²=0%). Subgroup analyses demonstrated consistent benefit for both laser-only and combined laser/cryotherapy approaches. Complications, when described, reduced the risk of RD during treatment, were typically mild, and included post-treatment retinal tears and epiretinal membrane formation; no adverse visual outcomes attributable to prophylactic treatment were consistently recorded. Prophylactic laser photocoagulation alone or in combination with cryotherapy appears effective and safe in reducing RD risk in the fellow eyes of patients with GRT. These findings support the selective use of prophylactic treatment in high-risk eyes; however, high-quality prospective studies are required to validate the long-term advantages.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.